STXV - ETF AI Analysis

Top Page

Strive 1000 Value ETF (STXV)

Rating:71Outperform

Price Target:―

STXV, the Strive 1000 Value ETF, earns a solid overall rating thanks to several high-quality holdings like Merck, Micron, and Johnson & Johnson, which bring strong financial performance, attractive growth opportunities, and supportive earnings call trends. Financial giants such as Wells Fargo and Bank of America also add to the fund’s appeal with robust profitability and generally positive outlooks, though issues like leverage, cash flow challenges, and pockets of weaker stability at holdings such as AbbVie and Citigroup slightly weigh on the rating. Investors should also note that multiple large positions in energy and financial stocks mean the fund is somewhat exposed to sector-specific risks.

Positive Factors

Solid Recent Performance

The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.

Strong Leading Holdings

Several of the largest positions, including major energy, health care, and technology names, have delivered strong year-to-date performance that supports the fund’s returns.

Broad Sector Diversification

Holdings are spread across many sectors such as financials, health care, technology, energy, and others, which helps reduce the impact if any one industry struggles.

Negative Factors

Heavy U.S. Concentration

The fund is invested almost entirely in U.S. companies, offering very limited geographic diversification outside the United States.

Weakness in Some Top Financial Holdings

Several large financial stocks in the top holdings have shown weak year-to-date performance, which can drag on overall returns if the sector stays under pressure.

Moderate Fund Size

With a relatively modest asset base, the ETF may be less liquid than larger, more established value funds, which could matter for investors trading bigger amounts.

STXV vs. SPDR S&P 500 ETF (SPY)

AUM74.89M

RegionNorth America

Expense Ratio0.18%

Beta0.66

IssuerStrive

Inception DateNov 10, 2022

Dividend Yield2.17%

Asset ClassEquity

Index TrackedBloomberg US 1000 Value

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume9,635

30 Day Avg. Volume7,613

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

39.29

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering701

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

STXV Summary

The Strive 1000 Value ETF (STXV) tracks the Bloomberg US 1000 Value Index, focusing on large U.S. companies that appear undervalued based on their fundamentals. It owns a wide mix of sectors like financials, health care, and energy, with well-known names such as Exxon Mobil and Johnson & Johnson among its top holdings. Investors might consider this ETF for broad diversification across many established companies and potential long-term growth plus dividends from value stocks. A key risk is that value stocks can fall out of favor and the ETF’s price can go up and down with the overall stock market.

How much will it cost me?The Strive 1000 Value ETF (Ticker: STXV) has an expense ratio of 0.18%, which means you’ll pay $1.80 per year for every $1,000 invested. This is lower than the average for actively managed funds because it is passively managed, tracking an index of large-cap value stocks.

What would affect this ETF?The Strive 1000 Value ETF could benefit from a favorable economic environment that supports value investing, such as rising interest rates, which often boost financial sector performance, or increased demand for energy and healthcare services, given its significant exposure to these sectors. However, challenges like regulatory changes affecting top holdings like Exxon Mobil or Johnson & Johnson, or economic slowdowns that impact consumer spending and cyclical sectors, could negatively affect the ETF's performance.

STXV Top 10 Holdings

STXV is leaning hard into classic U.S. value stories, with big banks and health care names setting the tone while energy and chips add some spark. Micron has been the clear engine lately, riding strong momentum in AI-related demand, while Exxon and Chevron are also pulling their weight as energy stays firm. On the defensive side, Johnson & Johnson and Merck look steady, quietly supporting the fund. The main drag comes from lagging financials like Bank of America and Wells Fargo, which are keeping overall performance from really breaking away.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
XOM	Exxon Mobil	3.49%	$2.61M	$626.04B	37.15%	74 Outperform
JNJ	Johnson & Johnson	2.79%	$2.09M	$586.69B	55.91%	78 Outperform
MU	Micron	2.62%	$1.96M	$463.33B	313.64%	79 Outperform
BAC	Bank of America	2.02%	$1.51M	$379.01B	11.90%	72 Outperform
MRK	Merck & Company	1.69%	$1.26M	$301.34B	46.26%	80 Outperform
CVX	Chevron	1.55%	$1.16M	$369.96B	18.28%	71 Outperform
ABBV	AbbVie	1.48%	$1.11M	$409.15B	20.03%	66 Neutral
UNH	UnitedHealth	1.45%	$1.08M	$265.58B	-44.00%	72 Outperform
WFC	Wells Fargo	1.35%	$1.01M	$268.99B	8.75%	80 Outperform
T	AT&T	1.16%	$871.20K	$200.85B	10.90%	71 Outperform

STXV Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

34.51

Positive

100DMA

33.35

Positive

200DMA

31.89

Positive

Market Momentum

MACD

0.63

Negative

RSI

70.41

Negative

STOCH

79.03

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For STXV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 35.67, equal to the 50-day MA of 34.51, and equal to the 200-day MA of 31.89, indicating a bullish trend. The MACD of 0.63 indicates Negative momentum. The RSI at 70.41 is Negative, neither overbought nor oversold. The STOCH value of 79.03 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for STXV.

STXV Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
STXV	―	―	$74.89M	0.18%	―
SPVM	―	―	$99.98M	0.39%	―
MAVF	―	―	$85.95M	0.75%	―
SPDV	―	―	$85.64M	0.29%	―
CGVV	―	―	$83.16M	0.33%	―
ITAN	―	―	$71.83M	0.50%	―

Performance Comparison

STXV

Strive 1000 Value ETF

36.59

6.00

19.61%

SPVM

Invesco S&P 500 Value with Momentum ETF

―

MAVF

Matrix Advisors Value ETF

―

SPDV

AAM S&P 500 High Dividend Value ETF

―

CGVV

Capital Group U.S. Large Value ETF

―

ITAN

Sparkline Intangible Value ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents